首页 | 本学科首页   官方微博 | 高级检索  
     

小细胞肺癌多药耐药基因的检测及临床应用研究
引用本文:蔡群 吴丽杰 等. 小细胞肺癌多药耐药基因的检测及临床应用研究[J]. 哈尔滨医药, 2003, 23(1): 4-6
作者姓名:蔡群 吴丽杰 等
作者单位:哈尔滨市第一医院 150010(蔡群,吴丽杰,王力栋),哈尔滨市第一医院 150010(李辉)
摘    要:目的:探讨多药耐药集团(MDR1)在小细胞肺癌化疗中的作用和地位,方法:采用逆转录-多聚酶链式反应技术(RT/PCR)和免疫细胞化学染色法,检测了32例(初治原发癌21例和复治转移癌11例)小细胞肺癌患者血液中的MDR1mRNA水平和多药耐药蛋白(P-170)的表达,并对两种方法进行了比较。结果:初治的原发癌MDR1基因阳性表达率为14.29%,P-170蛋白阳性表达为14.27%,复治转移癌的MDR1基因阳性表达率为72.73%,P-170蛋白阳性表达为63.64%(P<0.01),有显著性差异。MDR1的基因和蛋白两种而检测方法具有一定的一致性,以RT/PTR方法具有更强的敏感性,结论:复治转移癌组比初治组具有更普遍的抗药性,且主要是获得性抗药,MDR1基因表达可作为临床合理地制定化疗方案,预测化疗效果的重要参考指标。

关 键 词:临床应用 小细胞肺癌 多药耐药性 聚合酶链反应 基因表达

Detection of MDR1 in small cell lung cancer and its clinical application
Cai Qun Wu Lijie Wang Lidong Li Hui Departerment of Blood Bank,the First Hospital of Harbin,Harbin, China. Detection of MDR1 in small cell lung cancer and its clinical application[J]. harbin medical journal, 2003, 23(1): 4-6
Authors:Cai Qun Wu Lijie Wang Lidong Li Hui Departerment of Blood Bank  the First Hospital of Harbin  Harbin   China
Affiliation:Cai Qun Wu Lijie Wang Lidong Li Hui Departerment of Blood Bank,the First Hospital of Harbin,Harbin,150010 China
Abstract:Objective Toinvestigate the role of MDRl in chemotherapy of small cell lung cancer (SCLC). Methods The expression of MDRl mRNA and P-170 in samples from 32 patients with SCLC(21 cases of primary cancer and RT - PCR and immunnohistochemisty. Meanwhile ,a comparison was made between the two methods. Results The positive rate of MDRl mRNA expression was 14. 29% and 63. 64%, respectively,in 21 cases of primary cancer and 11 cases of metastatic cancer. There were significant differ- ences between the 2 groups of patients(p<0. 01). For detection of MDR1 mRNA and p -170,both techniques achieved the same results. However,RT -PCR was more sensitive. Conclusions Metastatic cancer has stronger drug resistance (mainly achieved drug resistance) than primary cancer. MDRl mRNA expression can be used as used as an important reference index for reasonable planning of chemotherapy and prediction of therapeutic efficacy.
Keywords:Small cell lung cancer Multi-drug resistance  RT - PCR  Gene expression
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号